rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
22
|
pubmed:dateCreated |
2006-6-6
|
pubmed:abstractText |
The safety of aspirin in heart failure (HF) has been called into question, particularly in those patients (1) without coronary disease, (2) with renal dysfunction, or (3) treated with low-dose angiotensin-converting enzyme (ACE) inhibitors and high-dose aspirin.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1524-4539
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
6
|
pubmed:volume |
113
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2572-8
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16735672-Aged,
pubmed-meshheading:16735672-Aged, 80 and over,
pubmed-meshheading:16735672-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:16735672-Anti-Inflammatory Agents, Non-Steroidal,
pubmed-meshheading:16735672-Aspirin,
pubmed-meshheading:16735672-Cohort Studies,
pubmed-meshheading:16735672-Coronary Disease,
pubmed-meshheading:16735672-Dose-Response Relationship, Drug,
pubmed-meshheading:16735672-Drug Interactions,
pubmed-meshheading:16735672-Drug Therapy, Combination,
pubmed-meshheading:16735672-Drug Toxicity,
pubmed-meshheading:16735672-Female,
pubmed-meshheading:16735672-Heart Failure,
pubmed-meshheading:16735672-Hemodynamics,
pubmed-meshheading:16735672-Humans,
pubmed-meshheading:16735672-Kidney Diseases,
pubmed-meshheading:16735672-Male,
pubmed-meshheading:16735672-Middle Aged,
pubmed-meshheading:16735672-Multivariate Analysis,
pubmed-meshheading:16735672-Odds Ratio,
pubmed-meshheading:16735672-Patient Readmission,
pubmed-meshheading:16735672-Prognosis,
pubmed-meshheading:16735672-Proportional Hazards Models,
pubmed-meshheading:16735672-Prospective Studies,
pubmed-meshheading:16735672-Time Factors,
pubmed-meshheading:16735672-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure.
|
pubmed:affiliation |
Division of General Internal Medicine, University of Alberta, Edmonton, Canada. Finlay.McAlister@ualberta.ca
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|